SCHEMBL472145

SCHEMBL472145

C=CCOc1ccc(C2(c3ccc(OCC=C)cc3)CCCCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB1 P20618 1/20 0.53
PSMB5 P28074 1/20 0.53
PSMB2 P49721 1/20 0.53
ALDH1A1 P00352 3/20 0.44
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CA12 O43570 3/20 0.44
CA1 P00915 3/20 0.44
CA9 Q16790 3/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 2/20 0.43
ADORA3 P0DMS8 1/20 0.41
CYP2D6 P10635 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL826438 0.98 PSMB1 (0.50) PSMB1PSMB5PSMB2ALDH1A1ESR1
SCHEMBL15869166 0.80 ALDH1A1 (0.42) PSMB1PSMB5PSMB2ALDH1A1CA12
SCHEMBL14289121 0.79 PSMB1 (0.56) PSMB1PSMB5PSMB2ALDH1A1ESR1
SCHEMBL13039984 0.79 ADORA3 (0.45) PSMB1PSMB5PSMB2ALDH1A1ESR1
SCHEMBL9320648 0.79 PSMB1 (0.46) PSMB1PSMB5PSMB2ALDH1A1ESR1
SCHEMBL9320722 0.78 PSMB1 (0.44) PSMB1PSMB5PSMB2ALDH1A1L3MBTL1
SCHEMBL15869193 0.77 MAPT (0.39) PSMB1PSMB5PSMB2ALDH1A1L3MBTL1
SCHEMBL12184176 0.77 CA12 (0.49) ALDH1A1CA12CA1CA9CA2
SCHEMBL14289122 0.77 PSMB1 (0.54) PSMB1PSMB5PSMB2ALDH1A1ESR1
SCHEMBL472144 0.77 ESR1 (0.65) PSMB1PSMB5PSMB2ALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9701874-B2 Conductive adhesive, anisotropic conductive film, and electronic device using same SHOWA DENKO K.K. (JP) 2017-07-11 US claimed
US-8143362-B2 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-03-27 US claimed
US-20100331444-A1 COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF 3M ESPE AG (A WHOLLY-OWNED SUBSIDUARY OF 3M COMPANY) 2010-12-30 US claimed
US-7807730-B2 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M ESPE AG (DE) 2010-10-05 US claimed
EP-2982727-B1 CONDUCTIVE ADHESIVE, ANISOTROPIC CONDUCTIVE FILM AND ELECTRONIC DEVICES USING BOTH SHOWA DENKO KK (JP) 2020-09-02 EP disclosed
US-9793456-B2 Molded resin body for surface-mounted light-emitting device, manufacturing method thereof, and surface-mounted light-emitting device KANEKA CORPORATION (JP) 2017-10-17 US disclosed
US-9793456-B2 Molded resin body for surface-mounted light-emitting device, manufacturing method thereof, and surface-mounted light-emitting device KANEKA CORPORATION (JP) 2017-10-17 US disclosed
US-9701874-B2 Conductive adhesive, anisotropic conductive film, and electronic device using same SHOWA DENKO K.K. (JP) 2017-07-11 US disclosed
US-9496468-B2 Curable resin composition, curable resin composition tablet, molded body, semiconductor package, semiconductor component and light emitting diode KANEKA CORPORATION (JP) 2016-11-15 US disclosed
US-9496468-B2 Curable resin composition, curable resin composition tablet, molded body, semiconductor package, semiconductor component and light emitting diode KANEKA CORPORATION (JP) 2016-11-15 US disclosed
US-9377690-B2 Compositon for forming metal oxide-containing film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-06-28 US disclosed
US-9377690-B2 Compositon for forming metal oxide-containing film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-06-28 US disclosed
US-7785715-B2 Compound with at least two carbon-carbon double bonds such as triallyl isocyanurate; compound with SiH groups such as reaction product of 1,3,5,7 tetramethylcyclotetrasiloxane and triallyl isocyanurate; coupler; and not less than 5% by weight of rutile TiO2 KANEKA CORPORATION (JP) 2010-08-31 US disclosed
EP-2216336-A1 PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION Kaneka Corporation (JP) 2010-08-11 EP disclosed
US-7371462-B2 1,3,5,7-tetramethylcyclotetrasiloxane and triallyl isocyanurate, a hydrosilylation catalyst, a silane coupling agent and/or an epoxy group-containing compound, and a silanol condensation catalyst KANEKA CORPORATION (JP) 2008-05-13 US disclosed
US-7371462-B2 1,3,5,7-tetramethylcyclotetrasiloxane and triallyl isocyanurate, a hydrosilylation catalyst, a silane coupling agent and/or an epoxy group-containing compound, and a silanol condensation catalyst KANEKA CORPORATION (JP) 2008-05-13 US disclosed
US-20060111464-A1 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M DEUTSCHLAND GMBH (DE) 2006-05-25 US disclosed
EP-1652889-A1 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M Espe AG (DE) 2006-05-03 EP disclosed
EP-1650263-A1 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M Espe AG (DE) 2006-04-26 EP disclosed
US-4292151-A MELT SPINNING THE BLOCK POLYMER WITH AN UNSATURATED COMPOUND; CURING WITH ACTINIC RADIATION TEIJIN LIMITED (JP) 1981-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331444-A1 COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF SMCHD1, CAD, ESD PSMB1 151/4885PSMB5 105/4885PSMB2 82/4885
US-20060111464-A1 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof CAD, SMCHD1, SUPT16H PSMB1 113/4885PSMB5 129/4885PSMB2 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.